Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2010Antiviral Therapy

von Willebrand Factor Antigen: A Novel On-Treatment Predictor of Response to Antiviral Therapy in Chronic Hepatitis C Genotypes 1 and 4

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSibylle PramhasMHMonika HomoncikPFPéter Ferenci

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pramhas et al. (2010) studied this question.

synapsesocial.com/papers/6a9f9c957e48e933bef3caeehttps://doi.org/10.3851/imp1654
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow2004 · 588 citations
  2. 2Peginterferon and Ribavirin for Chronic Hepatitis C2006 · 475 citations
  3. 3Treatment of von Willebrand's Disease2004 · 486 citations
  4. 4Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial2008 · 278 citations
  5. 5Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C2006 · 5 citations